Global Life Bioventure V Sarl 13D and 13G filings for Immunic, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 4:41 pm Purchase |
2022-12-20 | 13D | Immunic, Inc. IMUX |
Global Life Bioventure V Sarl | 1,849,786 4.200% |
43,873 (+2.43%) |
Filing |
| 2022-03-15 11:09 am Purchase |
2020-08-05 | 13D | Immunic, Inc. IMUX |
Global Life Bioventure V Sarl | 1,805,913 9.030% |
434,419 (+31.67%) |
Filing |